GAP43 and Cerebral ischemia: In another study, authors engineered exosomes containing QCT nanoparticles and monoclonal antibodies against GAP43 (mAb GAP43) and found a therapeutic effect in cerebral ischemia by decreasing reactive oxygen species (ROS) (46).